Advertisement

Current Cardiology Reports

, 17:111 | Cite as

Psychological Aspects of Cardiac Care and Rehabilitation: Time to Wake Up to Sleep?

  • Jonathan GallagherEmail author
  • Giulia Parenti
  • Frank Doyle
Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Psychological Aspects of Cardiovascular Diseases

Abstract

Psychological and psychosocial factors have long been linked to cardiovascular disease. These psychosocial factors, including low socioeconomic status, social support/isolation, stress and distress, personality, and sleep disturbance increase risk of cardiovascular events and negatively impact quality of life. These factors may have direct effects on cardiovascular disease via immune or neuroendocrine pathways, or more indirect effects, by, for example, limiting adherence to recommended therapies and cardiac rehabilitation. Most psychosocial risk factors can be assessed relatively easily using standardised tools. Sleep disturbance, in particular, is gaining evidence for its importance and may be crucial to address. While the management of certain psychosocial risk factors is an ethical requirement for care and improves quality of life, unfortunately there is little evidence that such strategies impact on ‘hard’ endpoints such as recurrent myocardial infarction. A comprehensive biopsychosocial approach to management of these psychosocial factors is required to maximise the benefits patients derive from cardiac care.

Keywords

Psychosocial risk factors (PSRFs) Cardiovascular disease Depression/anxiety Psychological management Cardiac rehabilitation Sleep 

Notes

Compliance with Ethical Guidelines

Conflict of Interest

Jonathan Gallagher and Giulia Parenti declare that they have no conflict of interest.

Frank Doyle reports personal fees from Novartis.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol. 2008;51(13):1237–46. doi: 10.1016/j.jacc.2007.12.024.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.••
    Pogosova N, Saner H, Pedersen SS, Cupples ME, McGee H, Hofer S, et al. Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2014. doi: 10.1177/2047487314543075. Excellent overview of PSRFs including recommendations for measurement.
  3. 3.
    Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364(9438):953–62. doi: 10.1016/S0140-6736(04)17019-0.PubMedCrossRefGoogle Scholar
  4. 4.
    Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A. Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol. 2009;6(11):712–22. doi: 10.1038/nrcardio.2009.163.PubMedCrossRefGoogle Scholar
  5. 5.
    Woodward M, Peters SA, Batty GD, Ueshima H, Woo J, Giles GG, et al. Socioeconomic status in relation to cardiovascular disease and cause-specific mortality: a comparison of Asian and Australasian populations in a pooled analysis. BMJ Open. 2015;5(3):e006408. doi: 10.1136/bmjopen-2014-006408.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Galobardes B, Smith GD, Lynch JW. Systematic review of the influence of childhood socioeconomic circumstances on risk for cardiovascular disease in adulthood. Ann Epidemiol. 2006;16(2):91–104. doi: 10.1016/j.annepidem.2005.06.053.PubMedCrossRefGoogle Scholar
  7. 7.
    Gerber Y, Goldbourt U, Drory Y. Israel study group on first acute myocardial I. Interaction between income and education in predicting long-term survival after acute myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2008;15(5):526–32. doi: 10.1097/HJR.0b013e328304feac.PubMedCrossRefGoogle Scholar
  8. 8.
    Gupta R, Islam S, Mony P, Kutty VR, Mohan V, Kumar R, Thakur J, Shankar VK, Mohan D, Vijayakumar K, Rahman O, Yusuf R, Iqbal R, Shahid M, Mohan I, Rangarajan S, Teo KK, Yusuf S. Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: the PURE study. Eur J Prev Cardiol. 2014.Google Scholar
  9. 9.
    Bruthans J, Mayer O Jr, De Bacquer D, De Smedt D, Reiner Z, Kotseva K, Cífková R, EUROASPIRE IV investigators. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2015.Google Scholar
  10. 10.
    Jankowski P, Pajak A, Lysek R, Lukaszewska A, Wolfshaut-Wolak R, Bogacki P, et al. Cardiac rehabilitation in real life. Medicine (Baltimore). 2015;94(32):e1257. doi: 10.1097/MD.0000000000001257.CrossRefGoogle Scholar
  11. 11.••
    Neubeck L, Freedman SB, Clark AM, Briffa T, Bauman A, Redfern J. Participating in cardiac rehabilitation: a systematic review and meta-synthesis of qualitative data. Eur J Prev Cardiol. 2012;19(3):494–503. An important insight into patient reported barriers.PubMedCrossRefGoogle Scholar
  12. 12.
    Gaalema DE, Higgins ST, Shepard DS, Suaya JA, Savage PD, Ades PA. State-by-state variations in cardiac rehabilitation participation are associated with educational attainment, income, and program availability. J Cardiopulm Rehabil Prev. 2014;34(4):248–54. doi: 10.1097/HCR.0000000000000059.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Alter DA, Franklin B, Ko DT, Austin PC, Lee DS, Oh PI, et al. Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction. PLoS One. 2014;8(6):e65130. doi: 10.1371/journal.pone.0065130.PubMedCrossRefGoogle Scholar
  14. 14.
    Dankner R, Drory Y, Geulayov G, Ziv A, Novikov I, Zlotnick AY, et al. A controlled intervention to increase participation in cardiac rehabilitation. Eur J Prev Cardiol. 2015;22(9):1121–8. doi: 10.1177/2047487314548815.PubMedCrossRefGoogle Scholar
  15. 15.
    Karmali KN, Davies P, Taylor F, Beswick A, Martin N, Ebrahim S. Promoting patient uptake and adherence in cardiac rehabilitation. Cochrane Database Syst Rev. 2014;6:CD007131. doi: 10.1002/14651858.CD007131.pub3.PubMedGoogle Scholar
  16. 16.
    Ades PA, Gaalema DE. Coronary heart disease as a case study in prevention: potential role of incentives. Prev Med. 2012;55(Suppl):S75–9. doi: 10.1016/j.ypmed.2011.12.025.PubMedCrossRefGoogle Scholar
  17. 17.
    Gaalema DE, Cutler AY, Higgins ST, Ades PA. Smoking and cardiac rehabilitation participation: associations with referral, attendance and adherence. Prev Med. 2015. doi: 10.1016/j.ypmed.2015.04.009.Google Scholar
  18. 18.
    Bucholz EM, Rathore SS, Gosch K, Schoenfeld A, Jones PG, Buchanan DM, et al. Effect of living alone on patient outcomes after hospitalization for acute myocardial infarction. Am J Cardiol. 2011;108(7):943–8. doi: 10.1016/j.amjcard.2011.05.023.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Barth J, Schneider S, von Kanel R. Lack of social support in the etiology and the prognosis of coronary heart disease: a systematic review and meta-analysis. Psychosom Med. 2010;72(3):229–38. doi: 10.1097/PSY.0b013e3181d01611.PubMedCrossRefGoogle Scholar
  20. 20.
    Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101(16):1919–24.PubMedCrossRefGoogle Scholar
  21. 21.
    Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289(23):3106–16. doi: 10.1001/jama.289.23.3106.PubMedCrossRefGoogle Scholar
  22. 22.
    Lurie I, Myers V, Goldbourt U, Gerber Y. Perceived social support following myocardial infarction and long-term development of frailty. Eur J Prev Cardiol. 2014.Google Scholar
  23. 23.
    Pinto BM, Dunsiger SI. Mediators of exercise maintenance after cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2015;35(1):13–20. doi: 10.1097/HCR.0000000000000065.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Burg MM, Barefoot J, Berkman L, Catellier DJ, Czajkowski S, Saab P, et al. Low perceived social support and post-myocardial infarction prognosis in the enhancing recovery in coronary heart disease clinical trial: the effects of treatment. Psychosom Med. 2005;67(6):879–88. doi: 10.1097/01.psy.0000188480.61949.8c.PubMedCrossRefGoogle Scholar
  25. 25.
    Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. J Am Med Assoc. 1959;169(12):1286–96.PubMedCrossRefGoogle Scholar
  26. 26.
    Myrtek M. Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility. Int J Cardiol. 2001;79(2–3):245–51.PubMedCrossRefGoogle Scholar
  27. 27.••
    Whalley B, Thompson DR, Taylor RS. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. Int J Behav Med. 2014;21(1):109–21. doi: 10.1007/s12529-012-9282-x. A clear overview of important RCTs in the area.PubMedCrossRefGoogle Scholar
  28. 28.
    Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svardsudd K. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med. 2011;171(2):134–40. doi: 10.1001/archinternmed.2010.510.PubMedCrossRefGoogle Scholar
  29. 29.
    Orth-Gomer K, Schneiderman N, Wang HX, Walldin C, Blom M, Jernberg T. Stress reduction prolongs life in women with coronary disease: the Stockholm Women’s Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovasc Qual Outcomes. 2009;2(1):25–32. doi: 10.1161/CIRCOUTCOMES.108.812859.PubMedCrossRefGoogle Scholar
  30. 30.
    Younge JO, Gotink RA, Baena CP, Roos-Hesselink JW, Hunink MM. Mind-body practices for patients with cardiac disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2014.Google Scholar
  31. 31.
    Smith TW. Concepts and methods in the study of anger, hostility and health. In: Siegman AW, Smith TW, editors. Anger, hostility and the heart. Hillsdale: Erlbaum; 1994. p. 23–42.Google Scholar
  32. 32.
    Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol. 2009;53(11):936–46. doi: 10.1016/j.jacc.2008.11.044.PubMedCrossRefGoogle Scholar
  33. 33.
    Skala JA, Freedland K, Carney R. Advances in psychotherapy—evidence based practice: heart disease. Cambridge: Hogrefe & Huber; 2005.Google Scholar
  34. 34.
    Mostofsky E, Maclure M, Tofler GH, Muller JE, Mittleman MA. Relation of outbursts of anger and risk of acute myocardial infarction. Am J Cardiol. 2013;112(3):343–8. doi: 10.1016/j.amjcard.2013.03.035.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Russell DC, Smith TL, Krahn DD, Graskamp P, Singh D, Kolden GG, et al. Effects of cognitive behavioral stress management on negative mood and cardiac autonomic activity in ICD recipients. Pacing Clin Electrophysiol. 2015;38(8):951–65. doi: 10.1111/pace.12668.PubMedCrossRefGoogle Scholar
  36. 36.
    Lavie CJ, Milani RV. Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol. 2004;93(3):336–9. doi: 10.1016/J.Amjcard.2003.10.015.PubMedCrossRefGoogle Scholar
  37. 37.
    Milani RV, Lavie CJ. Reducing psychosocial stress: a novel mechanism of improving survival from exercise training. Am J Med. 2009;122(10):931–8. doi: 10.1016/j.amjmed.2009.03.028.PubMedCrossRefGoogle Scholar
  38. 38.
    Arnold SV, Spertus JA, Nallamothu BK. The hostile heart: anger as a trigger for acute cardiovascular events. Eur Heart J. 2014;35(21):1359–60. doi: 10.1093/eurheartj/ehu097.PubMedCrossRefGoogle Scholar
  39. 39.
    Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67(1):89–97. doi: 10.1097/01.psy.0000149256.81953.49.PubMedCrossRefGoogle Scholar
  40. 40.
    Doyle F, McGee HM, Delaney M, Motterlini N, Conroy RM. Depressive vulnerabilities predict depression status and trajectories of depression over one year in persons with acute coronary syndrome. Gen Hosp Psychiatry. 2011;33(3):224–31. doi: 10.1016/j.genhosppsych.2011.03.008.PubMedCrossRefGoogle Scholar
  41. 41.
    Williams L, O’Connor RC, Howard S, Hughes BM, Johnston DW, Hay JL, et al. Type-D personality mechanisms of effect: the role of health-related behavior and social support. J Psychosom Res. 2008;64(1):63–9. doi: 10.1016/j.jpsychores.2007.06.008.PubMedCrossRefGoogle Scholar
  42. 42.
    Williams L, O’Connor RC, Grubb N, O’Carroll R. Type D personality predicts poor medication adherence in myocardial infarction patients. Psychol Health. 2011;26(6):703–12. doi: 10.1080/08870446.2010.488265.PubMedCrossRefGoogle Scholar
  43. 43.
    Williams L, Abbott C, Kerr R. Health behaviour mediates the relationship between Type D personality and subjective health in the general population. J Health Psychol. 2015. doi: 10.1177/1359105315571977.Google Scholar
  44. 44.
    Sogaro E, Schinina F, Burgisser C, Orso F, Pallante R, Aloi T, et al. Type D personality impairs quality of life, coping and short-term psychological outcome in patients attending an outpatient intensive program of cardiac rehabilitation. Monaldi Arch Chest Dis. 2010;74(4):181–91.PubMedGoogle Scholar
  45. 45.
    Denollet J, Schiffer AA, Spek V. A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes. 2010;3(5):546–57. doi: 10.1161/CIRCOUTCOMES.109.934406.PubMedCrossRefGoogle Scholar
  46. 46.
    Grande G, Romppel M, Barth J. Association between type D personality and prognosis in patients with cardiovascular diseases: a systematic review and meta-analysis. Ann Behav Med Publ Soc Behav Med. 2012;43(3):299–310. doi: 10.1007/s12160-011-9339-0.CrossRefGoogle Scholar
  47. 47.
    Pelle AJ, Pedersen SS, Schiffer AA, Szabo B, Widdershoven JW, Denollet J. Psychological distress and mortality in systolic heart failure. Circ Heart Fail. 2010;3(2):261–7. doi: 10.1161/CIRCHEARTFAILURE.109.871483.PubMedCrossRefGoogle Scholar
  48. 48.
    Coyne JC, Jaarsma T, Luttik ML, van Sonderen E, van Veldhuisen DJ, Sanderman R. Lack of prognostic value of type D personality for mortality in a large sample of heart failure patients. Psychosom Med. 2011;73(7):557–62. doi: 10.1097/PSY.0b013e318227ac75.PubMedCrossRefGoogle Scholar
  49. 49.
    Grande G, Romppel M, Vesper JM, Schubmann R, Glaesmer H, Herrmann-Lingen C. Type D personality and all-cause mortality in cardiac patients—data from a German cohort study. Psychosom Med. 2011;73(7):548–56. doi: 10.1097/PSY.0b013e318227a9bc.PubMedCrossRefGoogle Scholar
  50. 50.
    Dulfer K, Hazemeijer BA, Van Dijk MR, Van Geuns RJ, Daemen J, Van Domburg RT, et al. Prognostic value of type D personality for 10-year mortality and subjective health status in patients treated with percutaneous coronary intervention. J Psychosom Res. 2015. doi: 10.1016/j.jpsychores.2015.05.014.PubMedGoogle Scholar
  51. 51.
    de Voogd JN, Sanderman R, Coyne JC. A meta-analysis of spurious associations between type D personality and cardiovascular disease endpoints. Ann Behav Med Publ Soc Behav Med. 2012;44(1):136–7. doi: 10.1007/s12160-012-9356-7.CrossRefGoogle Scholar
  52. 52.
    Ferguson E, Williams L, O’Connor RC, Howard S, Hughes BM, Johnston DW, et al. A taxometric analysis of type-D personality. Psychosom Med. 2009;71(9):981–6. doi: 10.1097/PSY.0b013e3181bd888b.PubMedCrossRefGoogle Scholar
  53. 53.
    Pelle AJ, Erdman RA, van Domburg RT, Spiering M, Kazemier M, Pedersen SS. Type D patients report poorer health status prior to and after cardiac rehabilitation compared to non-type D patients. Ann Behav Med. 2008;36(2):167–75.PubMedCrossRefGoogle Scholar
  54. 54.
    Pelle AJ, van den Broek KC, Denollet J. Interventions in the context of the distressed (type D) personality. In: Dornelas E, editor. Stress proof the heart: behavioural interventions for cardiac patients. New York: Springer; 2012.Google Scholar
  55. 55.
    Karasek R, Theorell T. Healthy work: stress, productivity, and the reconstruction of working life. Basic books; 1992.Google Scholar
  56. 56.
    Kivimaki M, Nyberg ST, Batty GD, Fransson EI, Heikkila K, Alfredsson L, et al. Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet. 2012;380(9852):1491–7. doi: 10.1016/S0140-6736(12)60994-5.PubMedCentralPubMedCrossRefGoogle Scholar
  57. 57.
    Siegrist J. Adverse health effects of high-effort/low-reward conditions. J Occup Health Psychol. 1996;1(1):27.PubMedCrossRefGoogle Scholar
  58. 58.
    Eller NH, Netterstrom B, Gyntelberg F, Kristensen TS, Nielsen F, Steptoe A, et al. Work-related psychosocial factors and the development of ischemic heart disease: a systematic review. Cardiol Rev. 2009;17(2):83–97. doi: 10.1097/CRD.0b013e318198c8e9.PubMedCrossRefGoogle Scholar
  59. 59.
    Yonezawa R, Masuda T, Matsunaga A, Takahashi Y, Saitoh M, Ishii A, et al. Effects of phase II cardiac rehabilitation on job stress and health-related quality of life after return to work in middle-aged patients with acute myocardial infarction. Int Heart J. 2009;50(3):279–90.PubMedCrossRefGoogle Scholar
  60. 60.
    AACVPR. Guidelines for cardiac rehabilitation and secondary prevention programs (5th edition). Human Kinetics Press, 2013.Google Scholar
  61. 61.
    Cho EN, von Kanel R. Job stress and overcommitment in cardiac patients. In: Dornelas E, editor. Stress proof the heart: behavioural interventions for cardiac patients. New York: Springer; 2012.Google Scholar
  62. 62.
    Nawrot TS, Perez L, Kunzli N, Munters E, Nemery B. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet. 2011;377(9767):732–40. doi: 10.1016/S0140-6736(10)62296-9.PubMedCrossRefGoogle Scholar
  63. 63.
    Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–48. doi: 10.1056/NEJMoa043046.PubMedCrossRefGoogle Scholar
  64. 64.
    Steinberg JS, Arshad A, Kowalski M, Kukar A, Surna V, Vloka M, et al. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the world trade center attack. J Am Coll Cardiol. 2004;44(6):1261–4. doi: 10.1016/J.Jacc.2004.06.032.PubMedCrossRefGoogle Scholar
  65. 65.•
    Mostofsky E, Penner EA, Mittleman MA. Outbursts of anger as a trigger of acute cardiovascular events: a systematic review and meta-analysis. Eur Heart J. 2014;35(21):1404–10. doi: 10.1093/eurheartj/ehu033. Important meta-analysis quantifying the effects of anger on acute CVD onset.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Carroll D, Ebrahim S, Tilling K, MacLeod J, Smith GD. Admissions for myocardial infarction and World Cup football: database survey. Br Med J. 2002;325(7378):1439–42. doi: 10.1136/Bmj.325.7378.1439.CrossRefGoogle Scholar
  67. 67.
    Li J, Hansen D, Mortensen PB, Olsen J. Myocardial infarction in parents who lost a child: a nationwide prospective cohort study in Denmark. Circulation. 2002;106(13):1634–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Perkins-Porras L, Joekes K, Bhalla N, Sutherland C, Pollard M. Reporting of posttraumatic stress disorder and cardiac misconceptions following cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2015;35(4):238–45. doi: 10.1097/HCR.0000000000000100.PubMedCrossRefGoogle Scholar
  69. 69.
    Campbell TS, Stevenson A, Arena R, Hauer T, Bacon SL, Rouleau CR, et al. An investigation of the benefits of stress management within a cardiac rehabilitation population. J Cardiopulm Rehabil Prev. 2012;32(5):296–304.PubMedCrossRefGoogle Scholar
  70. 70.
    Whalley B, Rees K, Davies P, Bennett P, Ebrahim S, Liu ZL, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 2011;8:Cd002902. doi: 10.1002/14651858.Cd002902.PubMedGoogle Scholar
  71. 71.
    Cramer H, Lauche R, Haller H, Dobos G, Michalsen A. A systematic review of yoga for heart disease. Eur J Prev Cardiol. 2015;22(3):284–95. doi: 10.1177/2047487314523132.PubMedCrossRefGoogle Scholar
  72. 72.
    Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J. 2007;28(24):2972–84.PubMedCrossRefGoogle Scholar
  73. 73.
    Allan R. Observations of a clinical cardiac psychologist. In: Allan R, Fisher J, editors. Heart and mind: the practice of cardiac psychology. Washington: American Psychological Association; 2012. p. 475–86.Google Scholar
  74. 74.•
    Doyle F, McGee H, Conroy RM, Conradi HJ, Meijer A, Steeds RP, et al. Systematic review and individual patient data meta-analysis of sex differences in depression and prognosis in persons with myocardial infarction: a MINDMAPS study. Psychosom Med. 2015;77(4):419–28. doi: 10.1097/PSY.0000000000000174. This meta-analysis highlights the complexity of depression post-MI, with symptoms differentially associated with left ventricular function by sex.PubMedCrossRefGoogle Scholar
  75. 75.••
    Meijer A, Conradi HJ, Bos EH, Anselmino M, Carney RM, Denollet J, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. Br J Psychiatry. 2013;203(2):90–102. doi: 10.1192/bjp.bp.112.111195. Up to date meta-analysis of association between depression and post-MI morbidity and mortality.PubMedCrossRefGoogle Scholar
  76. 76.
    Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction—review of the evidence. J Gen Intern Med. 2006;21(1):30–8. doi: 10.1111/J.1525-1497.2005.00269x.PubMedCentralPubMedCrossRefGoogle Scholar
  77. 77.
    Kaptein KI, de Jonge P, van den Brink RH, Korf J. Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis. Psychosom Med. 2006;68(5):662–8. doi: 10.1097/01.psy.0000233237.79085.57.PubMedCrossRefGoogle Scholar
  78. 78.
    Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl EA, Singh PP, et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res. 2011;71(4):223–31. doi: 10.1016/j.jpsychores.2011.02.014.PubMedCrossRefGoogle Scholar
  79. 79.
    Whang W, Albert CM, Sears Jr SF, Lampert R, Conti JB, Wang PJ, et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol. 2005;45(7):1090–5. doi: 10.1016/j.jacc.2004.12.053.PubMedCrossRefGoogle Scholar
  80. 80.
    Tzeis S, Kolb C, Baumert J, Reents T, Zrenner B, Deisenhofer I, et al. Effect of depression on mortality in implantable cardioverter defibrillator recipients—findings from the prospective LICAD study. Pacing Clin Electrophysiol PACE. 2011;34(8):991–7. doi: 10.1111/j.1540-8159.2011.03081.x.PubMedCrossRefGoogle Scholar
  81. 81.
    Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure—a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527–37. doi: 10.1016/J.Jacc.2006.06.055.PubMedCrossRefGoogle Scholar
  82. 82.
    Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27(23):2763–74. doi: 10.1093/Eurheartj/Ehl338.PubMedCrossRefGoogle Scholar
  83. 83.•
    Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–69. doi: 10.1161/cir.0000000000000019. Review and recommendations of AHA working group on depression.PubMedCrossRefGoogle Scholar
  84. 84.
    Rieckmann N, Gerin W, Kronish IM, Burg MM, Chaplin WF, Kong G, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol. 2006;48(11):2218–22. doi: 10.1016/j.jacc.2006.07.063.PubMedCrossRefGoogle Scholar
  85. 85.
    Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J. 2006;152(5):922–7. doi: 10.1016/j.ahj.2006.05.014.PubMedCrossRefGoogle Scholar
  86. 86.
    Doyle F, Rohde D, Rutkowska A, Morgan K, Cousins G, McGee H. Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990 to 2013. Psychosom Med. 2014;76(1):44–57. doi: 10.1097/psy.0000000000000020.PubMedCrossRefGoogle Scholar
  87. 87.
    Glazer KM, Emery CF, Frid DJ, Banyasz RE. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2002;22(1):40–6.CrossRefGoogle Scholar
  88. 88.
    McGrady A, McGinnis R, Badenhop D, Bentle M, Rajput M. Effects of depression and anxiety on adherence to cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2009;29(6):358–64. doi: 10.1097/HCR.0b013e3181be7a8f.PubMedCrossRefGoogle Scholar
  89. 89.
    Pedersen SS, Denollet J, Daemen J, van de Sande M, de Jaegere PT, Serruys PW, et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res. 2007;62(4):455–61.PubMedCrossRefGoogle Scholar
  90. 90.
    Leroy M, Loas G, Perez-Diaz F. Anhedonia as predictor of clinical events after acute coronary syndromes: a 3-year prospective study. Compr Psychiatry. 2010;51(1):8–14.PubMedCrossRefGoogle Scholar
  91. 91.•
    de Miranda Azevedo R, Roest AM, Hoen PW, de Jonge P. Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol Med. 2014;44(13):2689–703. doi: 10.1017/S0033291714000063. Meta-analysis highlighting the importance of somatic depressive symptoms.PubMedCrossRefGoogle Scholar
  92. 92.
    Meijer A, Zuidersma M, de Jonge P. Depression as a non-causal variable risk marker in coronary heart disease. BMC Med. 2013;11:130. doi: 10.1186/1741-7015-11-130.PubMedCentralPubMedCrossRefGoogle Scholar
  93. 93.
    Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297(4):367–79.PubMedCrossRefGoogle Scholar
  94. 94.••
    Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med. 2010;170(7):600–8. This high-quality RCT demonstrates how best to manage depressive symptoms in this population.PubMedCentralPubMedCrossRefGoogle Scholar
  95. 95.
    Colquhoun DM, Bunker SJ, Clarke DM, Glozier N, Hare DL, Hickie IB, et al. Screening, referral and treatment for depression in patients with coronary heart disease. Med J Aust. 2013;198(9):483–4. doi: 10.5694/Mja13.10153.PubMedCrossRefGoogle Scholar
  96. 96.••
    Davidson KW, Bigger JT, Burg MM, Carney RM, Chaplin WF, Czajkowski S, et al. Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med. 2013;173(11):997–1004. doi: 10.1001/jamainternmed.2013.915. This high-quality RCT demonstrates how best to manage depressive symptoms in this population.PubMedCentralPubMedCrossRefGoogle Scholar
  97. 97.••
    Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Smith PJ, Hoffman BM, et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease. J Am Coll Cardiol. 2012;60(12):1053–63. doi: 10.1016/J.Jacc.2012.04.040. This high-quality RCT demonstrates how best to manage depressive symptoms in this population.PubMedCentralPubMedCrossRefGoogle Scholar
  98. 98.••
    Blumenthal JA, Babyak MA, O’Connor C, Keteyian S, Landzberg J, Howlett J, et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA. 2012;308(5):465–74. This high-quality RCT demonstrates how best to manage depressive symptoms in this population.PubMedCentralPubMedCrossRefGoogle Scholar
  99. 99.
    Ye S, Shaffer JA, Rieckmann N, Schwartz JE, Kronish IM, Ladapo JA, et al. Long-term outcomes of enhanced depression treatment in patients with acute coronary syndromes. Am J Med. 2014;127(10):1012–6. doi: 10.1016/j.amjmed.2014.05.004.PubMedCentralPubMedCrossRefGoogle Scholar
  100. 100.
    O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol. 2010;56(9):692–9. doi: 10.1016/j.jacc.2010.03.068.PubMedCentralPubMedCrossRefGoogle Scholar
  101. 101.
    Ladwig KH, Lederbogen F, Albus C, Angermann C, Borggrefe M, Fischer D, et al. Position paper on the importance of psychosocial factors in cardiology: update 2013. Ger Med Sci GMS e-journal. 2014;12:Doc09. doi: 10.3205/000194.PubMedGoogle Scholar
  102. 102.
    Cahill MC, Bilanovic A, Kelly S, Bacon S, Grace SL. Screening for depression in cardiac rehabilitation: a review. J Cardiopulm Rehabil Prev. 2015;35(4):225–30. doi: 10.1097/HCR.0000000000000101.PubMedCrossRefGoogle Scholar
  103. 103.
    Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of the prime-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA. 1999;282(18):1737–44.PubMedCrossRefGoogle Scholar
  104. 104.
    Shapiro P. Management of depression after myocardial infarction. Curr Cardiol Rep. 2015;17(10):634. doi: 10.1007/s11886-015-06.CrossRefGoogle Scholar
  105. 105.
    Tully PJ, Cosh SM. Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: a meta-analysis. J Health Psychol. 2013;18(12):1601–16. doi: 10.1177/1359105312467390.PubMedCrossRefGoogle Scholar
  106. 106.
    Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. The prevalence and persistence of depression and anxiety following myocardial infarction. Brit J Health Psych. 2002;7:11–21. doi: 10.1348/135910702169321.CrossRefGoogle Scholar
  107. 107.
    Easton K, Coventry P, Lovell K, Carter LA, Deaton C. Prevalence and measurement of anxiety in samples of patients with heart failure: meta-analysis. J Cardiovasc Nurs. 2015. doi: 10.1097/jcn.0000000000000265.PubMedGoogle Scholar
  108. 108.
    Morken IM, Isaksen K, Karlsen B, Norekval TM, Bru E, Larsen AI. Shock anxiety among implantable cardioverter defibrillator recipients with recent tachyarrhythmia. Pacing Clin Electrophysiol PACE. 2012;35(11):1369–76. doi: 10.1111/j.1540-8159.2012.03505.x.PubMedCrossRefGoogle Scholar
  109. 109.
    Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, Neria Y. Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review. PLoS One. 2012;7(6):e38915. doi: 10.1371/journal.pone.0038915.PubMedCentralPubMedCrossRefGoogle Scholar
  110. 110.
    Edmondson D, Kronish IM, Shaffer JA, Falzon L, Burg MM. Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J. 2013;166(5):806–14. doi: 10.1016/j.ahj.2013.07.031.PubMedCrossRefGoogle Scholar
  111. 111.
    Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry. 2008;65(11):1324–30. doi: 10.1001/archpsyc.65.11.1324.PubMedCrossRefGoogle Scholar
  112. 112.
    Tully PJ, Baune BT. Comorbid anxiety disorders alter the association between cardiovascular diseases and depression: the German national health interview and examination survey. Soc Psychiatry Psychiatr Epidemiol. 2014;49(5):683–91. doi: 10.1007/s00127-013-0784-x.PubMedCrossRefGoogle Scholar
  113. 113.
    Martens EJ, de Jonge P, Na B, Cohen BE, Lett H, Whooley MA. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Gen Psychiatry. 2010;67(7):750–8. doi: 10.1001/archgenpsychiatry.2010.74.PubMedCrossRefGoogle Scholar
  114. 114.
    Seldenrijk A, Vogelzangs N, Batelaan NM, Wieman I, van Schaik DJ, Penninx BJ. Depression, anxiety and 6-year risk of cardiovascular disease. J Psychosom Res. 2015;78(2):123–9. doi: 10.1016/j.jpsychores.2014.10.007.PubMedCrossRefGoogle Scholar
  115. 115.
    Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease a meta-analysis. J Am Coll Cardiol. 2010;56(1):38–46. doi: 10.1016/J.Jacc.2010.03.034.PubMedCrossRefGoogle Scholar
  116. 116.
    Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010;72(6):563–9. doi: 10.1097/PSY.0b013e3181dbff97.PubMedCrossRefGoogle Scholar
  117. 117.
    van Dijk MR, Utens EM, Dulfer K, Al-Qezweny MN, van Geuns RJ, Daemen J, van Domburg RT. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up. Eur J Prev Cardiol. 2015.Google Scholar
  118. 118.
    Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, et al. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol. 2012;109(9):1266–71. doi: 10.1016/j.amjcard.2011.12.017.PubMedCrossRefGoogle Scholar
  119. 119.
    Meyer T, Hussein S, Lange HW, Herrmann-Lingen C. Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting. Eur J Prev Cardiol. 2015;22(1):75–82. doi: 10.1177/2047487313505244.PubMedCrossRefGoogle Scholar
  120. 120.
    Huffman JC, Mastromauro CA, Beach SR, Celano CM, DuBois CM, Healy BC, et al. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med. 2014;174(6):927–35. doi: 10.1001/jamainternmed.2014.739.PubMedCrossRefGoogle Scholar
  121. 121.
    Celano CM, Suarez L, Matromauro C, Januzzi JL, Hjuffan JC. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2013;6:498–504.PubMedCrossRefGoogle Scholar
  122. 122.
    Hoekstra T, Jaarsma T, van Veldhuisen DJ, Hillege HL, Sanderman R, Lesman-Leegte I. Quality of life and survival in patients with heart failure. Eur J Heart Fail. 2013;15(1):94–102. doi: 10.1093/eurjhf/hfs148.PubMedCrossRefGoogle Scholar
  123. 123.
    Mastenbroek MH, Versteeg H, Zijlstra WP, Meine M, Spertus JA, Pedersen SS. Disease-specific health status as a predictor of mortality in patients with heart failure: a systematic literature review and meta-analysis of prospective cohort studies. Eur J Heart Fail. 2014;16(4):384–93. doi: 10.1002/Ejhf.55.PubMedCrossRefGoogle Scholar
  124. 124.
    Mommersteeg PMC, Denollet J, Spertus JA, Pedersen SS. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J. 2009;157(2):208–18. doi: 10.1016/J.Ahj.2008.09.020.PubMedCrossRefGoogle Scholar
  125. 125.
    Serber ER, Todaro JF, Tilkemeier PL, Niaura R. Prevalence and characteristics of multiple psychiatric disorders in cardiac rehabilitation patients. J Cardiopulm Rehabil Prev. 2009;29(3):161–8.PubMedCentralPubMedCrossRefGoogle Scholar
  126. 126.
    Cupples ME, Tully MA, Dempster M, Corrigan M, McCall DO, Downey B. Cardiac rehabilitation uptake following myocardial infarction: cross-sectional study in primary care. Br J Gen Pract. 2010;60(575):431–5. doi: 10.3399/Bjgp10x502155.PubMedCentralPubMedCrossRefGoogle Scholar
  127. 127.
    Anderson L, Taylor RS. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;12:Cd011273.PubMedGoogle Scholar
  128. 128.
    De Smedt D, Clays E, Annemans L, Boudrez H, De Sutter J, Doyle F, et al. The association between self-reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey. Eur J Prev Cardiol. 2014;21(7):796–805. doi: 10.1177/2047487312473846.PubMedCrossRefGoogle Scholar
  129. 129.
    Janssen V, De Gucht V, van Exel H, Maes S. Changes in illness perceptions and quality of life during participation in cardiac rehabilitation. Int J Behav Med. 2013;20(4):582–9. doi: 10.1007/s12529-012-9260-3.PubMedCrossRefGoogle Scholar
  130. 130.
    Oldridge N, Hofer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21(1):90–7. doi: 10.1177/2047487312450544.PubMedCrossRefGoogle Scholar
  131. 131.
    Oldridge N, Hofer S, McGee H, Conroy R, Doyle F, Saner H, et al. The HeartQoL: part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21(1):98–106. doi: 10.1177/2047487312450545.PubMedCrossRefGoogle Scholar
  132. 132.
    Hofer S, Saleem A, Stone J, Thomas R, Tulloch H, Oldridge N. The MacNew heart disease health-related quality of life questionnaire in patients with angina and patients with ischemic heart failure. Value Health. 2012;15(1):143–50. doi: 10.1016/j.jval.2011.07.003.PubMedCrossRefGoogle Scholar
  133. 133.
    Hansen TB, Thygesen LC, Zwisler AD, Helmark L, Hoogwegt M, Versteeg H, et al. Self-reported health-related quality of life predicts 5-year mortality and hospital readmissions in patients with ischaemic heart disease. Eur J Prev Cardiol. 2015;22(7):882–9. doi: 10.1177/2047487314535682.PubMedCrossRefGoogle Scholar
  134. 134.
    Höfer S, Benzer W, Oldridge N. Change in health-related quality of life in patients with coronary artery disease predicts 4-year mortality. Int J Cardiol. 2014;174(1):7–12. doi: 10.1016/j.ijcard.2014.03.144.PubMedCrossRefGoogle Scholar
  135. 135.
    Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2014;35(21):1382–93. doi: 10.1093/eurheartj/eht019.PubMedCrossRefGoogle Scholar
  136. 136.
    Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011;124(19):2073–81. doi: 10.1161/circulationaha.111.025858.PubMedCrossRefGoogle Scholar
  137. 137.
    Reitav J. Managing sleep problems among cardiac patients. In: Dornelas E, editor. Stress proof the heart: behavioural interventions for cardiac patients. New York: Springer; 2012.Google Scholar
  138. 138.
    Vyas MV, Garg AX, Iansavichus AV, Costella J, Donner A, Laugsand LE, et al. Shift work and vascular events: systematic review and meta-analysis. BMJ. 2012;345:e4800.PubMedCentralPubMedCrossRefGoogle Scholar
  139. 139.
    Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–92. doi: 10.1093/eurheartj/ehr007.PubMedCrossRefGoogle Scholar
  140. 140.
    Rozanski A. Behavioral cardiology: current advances and future directions. J Am Coll Cardiol. 2014;64(1):100–10. doi: 10.1016/j.jacc.2014.03.047.PubMedCrossRefGoogle Scholar
  141. 141.
    Gangwisch JE. A review of evidence for the link between sleep duration and hypertension. Am J Hypertens. 2014;27(10):1235–42. doi: 10.1093/ajh/hpu071.PubMedCentralPubMedCrossRefGoogle Scholar
  142. 142.
    Jackowska M, Steptoe A. Sleep and future cardiovascular risk: prospective analysis from the English longitudinal study of ageing. Sleep Med. 2015;16(6):768–74. doi: 10.1016/j.sleep.2015.02.530.PubMedCrossRefGoogle Scholar
  143. 143.
    Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab. 2010;24(5):731–43. doi: 10.1016/j.beem.2010.07.001.PubMedCentralPubMedCrossRefGoogle Scholar
  144. 144.
    Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, Verschuren WM. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study. Eur J Prev Cardiol. 2014;21(11):1367–75. doi: 10.1177/2047487313493057.PubMedCrossRefGoogle Scholar
  145. 145.
    Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003;290(14):1906–14. doi: 10.1001/jama.290.14.1906.PubMedCrossRefGoogle Scholar
  146. 146.
    Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1910–3. doi: 10.1164/ajrccm.164.10.2101072.PubMedCrossRefGoogle Scholar
  147. 147.
    Skobel E, Kamke W, Bonner G, Alt B, Purucker HC, Schwaab B, et al. Risk factors for, and prevalence of, sleep apnoea in cardiac rehabilitation facilities in Germany: the reha-sleep registry. Eur J Prev Cardiol. 2015;22(7):820–30. doi: 10.1177/2047487314537916.PubMedCrossRefGoogle Scholar
  148. 148.
    Hargens TA, Aron A, Newsome LJ, Austin JL, Shafer BM. Effects of obstructive sleep apnea on hemodynamic parameters in patients entering cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2015;35(3):181–5. doi: 10.1097/HCR.0000000000000102.PubMedCrossRefGoogle Scholar
  149. 149.
    Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50(14):1310–4. doi: 10.1016/j.jacc.2007.06.028.PubMedCrossRefGoogle Scholar
  150. 150.
    Milleron O, Pilliere R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 2004;25(9):728–34. doi: 10.1016/j.ehj.2004.02.008.PubMedCrossRefGoogle Scholar
  151. 151.
    Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080–111. doi: 10.1161/circulationaha.107.189375.PubMedCrossRefGoogle Scholar
  152. 152.
    Ong JC, Crawford MR. Insomnia and obstructive sleep apnea. Sleep Med Clin. 2013;8(3):389–98. doi: 10.1016/j.jsmc.2013.04.004.PubMedCentralPubMedCrossRefGoogle Scholar
  153. 153.
    Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014;21(1):57–64. doi: 10.1177/2047487312460020.PubMedCrossRefGoogle Scholar
  154. 154.
    Grandner MA, Buxton OM, Jackson N, Sands-Lincoln M, Pandey A, Jean-Louis G. Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep. 2013;36(5):769–779. doi: 10.5665/sleep.2646.PubMedCentralPubMedGoogle Scholar
  155. 155.
    Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60(4):929–35. doi: 10.1161/hypertensionaha.112.193268.PubMedCentralPubMedCrossRefGoogle Scholar
  156. 156.
    Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17(4):241–54. doi: 10.1016/j.smrv.2012.09.005.PubMedCentralPubMedCrossRefGoogle Scholar
  157. 157.
    Li Y, Zhang X, Winkelman JW, Redline S, Hu FB, Stampfer M, et al. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 2014;129(7):737–46. doi: 10.1161/circulationaha.113.004500.PubMedCentralPubMedCrossRefGoogle Scholar
  158. 158.
    Carney CE, Segal ZV, Edinger JD, Krystal AD. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry. 2007;68(2):254–60.PubMedCrossRefGoogle Scholar
  159. 159.
    Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489–95.PubMedCentralPubMedGoogle Scholar
  160. 160.
    Coryell VT, Ziegelstein RC, Hirt K, Quain A, Marine JE, Smith MT. Clinical correlates of insomnia in patients with acute coronary syndrome. Int Heart J. 2013;54(5):258–65.PubMedCrossRefGoogle Scholar
  161. 161.
    Banack HR, Holly CD, Lowensteyn I, Masse L, Marchand S, Grover SA, et al. The association between sleep disturbance, depressive symptoms, and health-related quality of life among cardiac rehabilitation participants. J Cardiopulm Rehabil Prev. 2014;34(3):188–94. doi: 10.1097/HCR.0000000000000054.PubMedCrossRefGoogle Scholar
  162. 162.
    Le Grande MR, Jackson AC, Murphy BM, Thomason N. Relationship between sleep disturbance, depression and anxiety in the 12 months following a cardiac event. Psychol Health Med. 2015;11:1–8.Google Scholar
  163. 163.
    Canadian Association for Cardiac Rehabilitation. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention: translating knowledge into action. 2009.Google Scholar
  164. 164.
    Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–21.PubMedCrossRefGoogle Scholar
  165. 165.
    Morin M. Insomnia: psychological assessment and management. New York: Guildford Press; 1993.Google Scholar
  166. 166.
    Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005–15.PubMedCentralPubMedCrossRefGoogle Scholar
  167. 167.
    Espie CA. “Stepped care”: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep. 2009;32(12):1549–58.PubMedCentralPubMedGoogle Scholar
  168. 168.
    Conley S, Redeker NS. Cognitive behavioral therapy for insomnia in the context of cardiovascular conditions. Curr Sleep Med Rep. 2015;1:157–65. doi: 10.1007/s40675-015-0019-7.PubMedCrossRefGoogle Scholar
  169. 169.
    Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Breen EC, Witarama T, et al. Cognitive behavioural therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep. 2014;37(9):1543–52. doi: 10.5665/sleep.4008.PubMedCentralPubMedGoogle Scholar
  170. 170.
    Redline S, Foody J. Sleep disturbances: time to join the top 10 potentially modifiable cardiovascular risk factors? Circulation. 2011;124(19):2049–51. doi: 10.1161/CIRCULATIONAHA.111.062190.PubMedCrossRefGoogle Scholar
  171. 171.
    Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. 2013;2013:695925. doi: 10.1155/2013/695925.PubMedCentralPubMedCrossRefGoogle Scholar
  172. 172.••
    Steptoe A, Kivimaki M. Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health. 2013;34:337–54. doi: 10.1146/annurev-publhealth-031912-114452. An excellent overview of current knowledge of direct mechanisms linking stress to CVD.PubMedCrossRefGoogle Scholar
  173. 173.
    Hamer M, Molloy GJ, Stamatakis E. Psychological distress as a risk factor for cardiovascular events. J Am Coll Cardiol. 2008;52(25):2156–62. doi: 10.1016/J.Jacc.2008.08.057.PubMedCrossRefGoogle Scholar
  174. 174.
    Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA J Am Med Assoc. 2010;303(12):1159–66. doi: 10.1001/Jama.2010.297.CrossRefGoogle Scholar
  175. 175.
    Rahimi AR, Spertus JA, Reid KJ, Bernheim SM, Krumholz HM. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA. 2007;297(10):1063–72. doi: 10.1001/jama.297.10.1063.PubMedCrossRefGoogle Scholar
  176. 176.
    Alcantara C, Muntner P, Edmondson D, Safford MM, Redmond N, Colantonio LD, et al. Perfect storm: concurrent stress and depressive symptoms increase risk of myocardial infarction or death. Circ Cardiovasc Qual Outcomes. 2015;8(2):146–54. doi: 10.1161/circoutcomes.114.001180.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Jonathan Gallagher
    • 1
    Email author
  • Giulia Parenti
    • 2
  • Frank Doyle
    • 3
  1. 1.Department of Cardiology (Cardiac Rehabilitation)Beaumont HospitalDublin 9Ireland
  2. 2.Department of General PsychologyUniversity of PaduaPaduaItaly
  3. 3.Department of PsychologyRoyal College of Surgeons in IrelandDublin 2Ireland

Personalised recommendations